Company Name:CRISPR Therapeutics AG
CEO:

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Global Market

Country: USA

Description: CRISPR Therapeutics AG is a gene editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics.


Key numbers

Market Capitalization:3467963486
Shares Outstanding: 59454200
Float: 35676325
Next Earning Date:2020-03-06
TTm EPS: -0.3349
TTm Dividend Rate:
200 days moving average:48.39
50 days moving average: 62.79
One day percent Change: -2.18



2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,